×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
中国医学科学院 北... [24]
复旦大学上海医学院 [10]
厦门大学 [3]
合肥物质科学研究院 [3]
上海药物研究所 [2]
四川大学 [2]
更多...
内容类型
期刊论文 [51]
会议论文 [2]
发表日期
2021 [1]
2020 [3]
2019 [10]
2018 [6]
2017 [4]
2016 [6]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共53条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Transcriptome Regulation by Oncogenic ALK Pathway in Mammalian Cortical Development Revealed by Single-Cell RNA Sequencing
期刊论文
CEREBRAL CORTEX, 2021, 卷号: 31, 期号: 8, 页码: 3911-3924
作者:
Mao, Rui
;
Zhang, Xiaoyun
;
Kong, Youyong
;
Wu, Shanshan
;
Huo, Hai-qin
收藏
  |  
浏览/下载:34/0
  |  
提交时间:2021/08/17
anaplastic lymphoma kinase
cerebral organoid
neurodevelopment
neural progenitor cell
single-cell RNA sequencing
The deep learning model combining CT image and clinicopathological information for predicting ALK fusion status and response to ALK-TKI therapy in non-small cell lung cancer patients
期刊论文
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020
作者:
Song, Zhengbo
;
Liu, Tianchi
;
Shi, Lei
;
Yu, Zongyang
;
Shen, Qing
收藏
  |  
浏览/下载:18/0
  |  
提交时间:2020/10/26
Deep learning model
Anaplastic lymphoma kinase
Computed tomography
Non-small cell lung cancer
CT-Based Radiomic Signature as a Prognostic Factor in Stage IV ALK-Positive Non-small-cell Lung Cancer Treated With TKI Crizotinib: A Proof-of-Concept Study
期刊论文
FRONTIERS IN ONCOLOGY, 2020, 卷号: 10, 页码: 9
作者:
Li, Hailin
;
Zhang, Rui
;
Wang, Siwen
;
Fang, Mengjie
;
Zhu, Yongbei
收藏
  |  
浏览/下载:48/0
  |  
提交时间:2020/04/07
computed tomography
radiomics
non-small-cell lung cancer
tyrosine kinase inhibitor resistance
anaplastic lymphoma kinase
Evaluating Solid Lung Adenocarcinoma Anaplastic Lymphoma Kinase Gene Rearrangement Using Noninvasive Radiomics Biomarkers
期刊论文
ONCOTARGETS AND THERAPY, 2020, 卷号: 13
作者:
Ma, De-Ning
;
Gao, Xin-Yi
;
Dan, Yi-Bo
;
Zhang, An-Ni
;
Wang, Wei-Jun
收藏
  |  
浏览/下载:23/0
  |  
提交时间:2020/11/26
radiogenomics
SVM
non-small cell lung cancer
anaplastic lymphoma kinase
epidermal growth factor receptor
Intracranial inflammatory myofibroblastic tumor with negative expression of anaplastic lymphoma kinase: a case report and review of the literature
期刊论文
World Neurosurgery, 2019
作者:
;
Yang Chen
;
;
Xiujuan Wu
;
Xiaoke Wang
收藏
  |  
浏览/下载:23/0
  |  
提交时间:2019/12/05
Inflammatory myofibroblastic tumor
Central nervous system
Anaplastic lymphoma kinase
Chinese perspectives on clinical efficacy and safety of alectinib in patients with ALK-positive advanced non-small cell lung cancer
期刊论文
ONCOTARGETS AND THERAPY, 2019, 卷号: 12
作者:
Yu, Hui
;
Sun, Si
;
Hu, Xingjiang
;
Xia, Jinjing
;
Wang, Jialei
收藏
  |  
浏览/下载:25/0
  |  
提交时间:2019/12/05
NSCLC
anaplastic lymphoma kinase
alectinib
tyrosine kinase inhibitor
ALK-G1269A mutation in epithelioid inflammatory myofibroblastic sarcoma after progression on crizotinib: A case report
期刊论文
ONCOLOGY LETTERS, 2019, 卷号: 17, 期号: 2
作者:
Xu, Xiaojing
;
Li, Hong
;
Peng, Ke
;
Yu, Yiyi
;
Chen, Lingli
收藏
  |  
浏览/下载:22/0
  |  
提交时间:2019/12/05
epithelioid inflammatory myofibroblastic sarcoma
anaplastic lymphoma kinase
kinase inhibitor
crizotinib
Brigatinib
drug resistance
Treatment Optimization for Brain Metastasis from Anaplastic Lymphoma Kinase Rearrangement Non-Small-Cell Lung Cancer
期刊论文
2019, 页码: 1-8
作者:
Wang Wenhui
;
Sun Xin
;
Hui Zhouguang
收藏
  |  
浏览/下载:27/0
  |  
提交时间:2020/01/03
Anaplastic lymphoma kinase
Brain metastasis
Non-small-cell lung cancer
Radiation therapy
Tyrosine kinase inhibitor
Elevated levels of pre-treatment lactate dehydrogenase are an unfavorable predictor factor in patients with EML4-ALK rearrangement non-small cell lung cancer treated with crizotinib
期刊论文
2019, 卷号: 11, 页码: 8191-8200
作者:
Liang Hongge
;
Ma Di
;
Xu Yan
;
Zhao Jing
;
Chen Minjiang
收藏
  |  
浏览/下载:28/0
  |  
提交时间:2020/01/03
crizotinib
echinoderm microtubule-associated protein-like 4–anaplastic lymphoma kinase
lactate dehydrogenase
non-small cell lung cancer
progression-free survival
Treatment duration as a surrogate endpoint to evaluate the efficacy of crizotinib in sequential therapy for patients with advanced ALK-positive non-small cell lung cancer: A retrospective, real-world study
期刊论文
2019, 卷号: 8, 期号: 13, 页码: 5823-5830
作者:
Yang Guangjian
;
Ma Di
;
Xu Haiyan
;
Yang Lu
;
Li Junling
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2020/01/03
anaplastic lymphoma kinase inhibitor
crizotinib
crizotinib continuation beyond progressive disease
non-small cell lung cancer
treatment duration
©版权所有 ©2017 CSpace - Powered by
CSpace